Nasus Pharma NSRX
NYSE NSRX
$3.69 +0.08 (+2.22%)
At close: Sep 30, 2026 · 4:00 PM EDT

Nasus Pharma (NSRX) Accounts Payables (2024 - 2026)

Updated

Nasus Pharma (NSRX) posted Accounts Payables of $347,000 for Q2 2026, down 47.7% from $664,000 a year earlier.

Analysis

Nasus Pharma (NSRX) Accounts Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma's Accounts Payables came in at $829,000, down 16.0% from FY2024.

  • In prior years, Nasus Pharma's Accounts Payables was $987,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Nasus Pharma 33.27 Mn 33.27 Mn - 347,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 347,000.00
Dec 31, 2025 829,000.00
Jun 30, 2025 664,000.00
Dec 31, 2024 987,000.00
API Access

Nasus Pharma Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=NSRX&period=max&api_key=YOUR_API_KEY